MAIA Biotechnology, Inc. (MAIA) Earnings History
Net Loss7 years of earnings data (2019–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
MAIA Biotechnology, Inc. (MAIA) Earnings Overview
As of June 4, 2026, MAIA Biotechnology, Inc. (MAIA) reported trailing twelve-month net income of -$24M, reflecting +33.3% year-over-year growth. The company earned $-0.76 per diluted share over the past four quarters.
Looking at the long-term picture, MAIA's historical earnings data spans multiple years. The company achieved its highest annual net income of -$6M in fiscal 2019.
MAIA Biotechnology, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including TELO (-$9M net income), IMVT (-$506M net income), AGEN ($65M net income, 0.1% margin), MAIA has comparable earnings metrics. Compare MAIA vs TELO →
MAIA Earnings vs Peers
Earnings metrics vs comparable public companies
MAIA Historical Earnings Data (2019–2025)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$22M | +3.7% | -$24M | $-0.70 | - | - |
| 2024 | -$23M | -17.6% | -$17M | $-1.05 | - | - |
| 2023 | -$20M | -25.4% | -$20M | $-1.49 | - | - |
| 2022 | -$16M | -26.1% | -$16M | $-1.70 | - | - |
| 2021 | -$13M | -88.4% | -$8M | $-1.18 | - | - |
| 2020 | -$7M | -2.2% | -$7M | $-0.62 | - | - |
| 2019 | -$6M | - | -$7M | $-0.61 | - | - |
Download Data
Export MAIA earnings history in CSV or JSON format
Free sign-in required to download data
What if you invested $1,000 in MAIA back in 2019?
Total return with dividends reinvested · 7+ years of data
Calculate ReturnsHow much would $100/month in MAIA be worth today?
Dollar cost averaging vs lump sum · see how regular investing compounds over time
Run the NumbersIs MAIA Undervalued Right Now?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationMAIA vs DBVT — which is the better buy?
Side-by-side revenue, margins, P/E and 10-year returns vs DBV Technologies S.A..
Compare NowMAIA — Frequently Asked Questions
Quick answers to the most common questions about buying MAIA stock.
What is MAIA earnings per share (EPS)?
MAIA trailing twelve-month (TTM) diluted EPS is $-0.76, reflecting +33.3% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2019 to 2025 is available in the table on this page.
What is MAIA Biotechnology, Inc.'s net income?
MAIA Biotechnology, Inc. (MAIA) trailing twelve-month net income is $-24M as of 2025. Earnings grew +33.3% year-over-year.
Is MAIA profitable?
MAIA is not currently profitable on a TTM basis, reporting a net loss of $-24M. Net margin is N/A. Investors should monitor for a return to profitability.
What is MAIA's earnings growth rate?
MAIA compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2019 to 2025.
What are MAIA's profit margins?
MAIA Biotechnology, Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -745.2%.
Is MAIA growing earnings?
Yes, MAIA earnings are accelerating — EPS growth of +33.3% exceeds the 5-year CAGR of N/A. TTM net income reached $-24M. Earnings momentum is strengthening.
What was MAIA's best earnings year?
MAIA Biotechnology, Inc.'s highest annual net income on record is $-6M, achieved in fiscal year 2019. Earnings history on this page spans 2019 to 2025 and includes all annual and quarterly figures.
What were MAIA's earnings last quarter?
MAIA's most recent reported quarter was Q1 2026. Net income was $-6M with diluted EPS of $-0.14. For a full breakdown of all quarters, see the quarterly earnings table on this page.